FI870140A - Orala vacciner. - Google Patents
Orala vacciner. Download PDFInfo
- Publication number
- FI870140A FI870140A FI870140A FI870140A FI870140A FI 870140 A FI870140 A FI 870140A FI 870140 A FI870140 A FI 870140A FI 870140 A FI870140 A FI 870140A FI 870140 A FI870140 A FI 870140A
- Authority
- FI
- Finland
- Prior art keywords
- vacciner
- orala
- orala vacciner
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0006—Contraceptive vaccins; Vaccines against sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPH056685 | 1985-05-15 | ||
AUPH310485 | 1985-10-25 | ||
PCT/AU1986/000135 WO1986006635A1 (en) | 1985-05-15 | 1986-05-14 | Oral vaccines |
Publications (2)
Publication Number | Publication Date |
---|---|
FI870140A true FI870140A (fi) | 1987-01-14 |
FI870140A0 FI870140A0 (fi) | 1987-01-14 |
Family
ID=25642944
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI870140A FI870140A0 (fi) | 1985-05-15 | 1987-01-14 | Orala vacciner. |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0222835B2 (fi) |
JP (1) | JP2761849B2 (fi) |
CN (1) | CN86103835A (fi) |
CA (1) | CA1340555C (fi) |
DE (1) | DE3650082T3 (fi) |
DK (1) | DK171846B1 (fi) |
ES (1) | ES8900006A1 (fi) |
FI (1) | FI870140A0 (fi) |
HK (1) | HK29896A (fi) |
IL (1) | IL78775A (fi) |
NZ (1) | NZ216162A (fi) |
WO (1) | WO1986006635A1 (fi) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE8601940D0 (sv) * | 1986-04-25 | 1986-04-25 | Kabigen Ab | Preparation of fused proteins, antibodies and processes therefor |
US4822611A (en) * | 1986-12-09 | 1989-04-18 | Immunotec, Inc. | Oral hyposensitization in the treatment of allergies |
US5112749A (en) * | 1987-10-02 | 1992-05-12 | Praxis Biologics, Inc. | Vaccines for the malaria circumsporozoite protein |
US5135918A (en) * | 1988-03-21 | 1992-08-04 | Broncorp | Method for decreasing reaginic antibody levels |
EP0396653A1 (en) * | 1988-08-30 | 1990-11-14 | Applied Research Systems ARS Holding N.V. | Recombinant fusion proteins for altering hormone secretion |
KR900701152A (ko) * | 1988-09-06 | 1990-12-01 | 원본미기재 | 유전자 변환식물, 이로부터 얻어진 조성물 및 그 제조방법 |
US6043057A (en) * | 1988-09-16 | 2000-03-28 | Vitec Aktiebolag | Recombinant systems for expression of the cholera B-sub-unit with the aid of foreign promoters and/or leader peptides |
FR2636842B1 (fr) * | 1988-09-27 | 1994-06-10 | Liege Universite Etat | Proteine de fusion d'une sequence derivee de la sous-unite b de la toxine cholerique et d'un antigene heterologue doue de proprietes immunogenes, compositions de vaccins les contenant et acides nucleiques recombinants contenant une sequence de nucleotides codant pour ladite proteine de fusion |
WO1990006366A1 (en) * | 1988-12-07 | 1990-06-14 | University Of Leicester | Heat-labile toxin b subunit fusion proteins |
WO1990007525A1 (en) * | 1989-01-06 | 1990-07-12 | The Regents Of The University Of California | Keratoconjunctivitis cytotoxin and methods for its use and production |
US6413523B1 (en) * | 1989-06-02 | 2002-07-02 | The United States Of America As Represented By The Secretary Of The Navy | Pharmaceutical composition of escherichia coli heat-labile enterotoxin adjuvant and methods of use |
ATE99331T1 (de) * | 1989-09-08 | 1994-01-15 | Takeda Chemical Industries Ltd | Fusionsproteine und herstellung davon. |
US5032405A (en) * | 1989-09-27 | 1991-07-16 | Warner-Lambert Company | Oral pharmaceutical composition for acid sensitive proteinaceous agents |
US5378815A (en) * | 1989-10-20 | 1995-01-03 | National Research Council Canada | Process for indirect targeted immunocytolysis |
CA2050425A1 (en) * | 1990-09-03 | 1992-03-04 | Yoshiaki Uda | Pharmaceutical composition and its mucous use |
US5241053A (en) * | 1990-09-05 | 1993-08-31 | Takeda Chemical Industries, Ltd. | Fused proteins comprising glycoprotein gD of HSV-1 and LTB |
US5843463A (en) * | 1990-12-21 | 1998-12-01 | Antexbiologics, Inc. | Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae |
ES2131066T3 (es) * | 1990-12-21 | 1999-07-16 | Antex Biolog Inc | Vacuna de conjugacion de oligosacarido con adhesina para hi(haemophilus influenzae). |
PT501882E (pt) * | 1991-03-01 | 2000-12-29 | Merial Sas | Processo de imunoneutralizacao anti-lhrm de animais domesticos machos nao castrados e peptido para esse fim |
IE921050A1 (en) * | 1991-04-02 | 1992-10-07 | Biotech Australia Pty Ltd | Oral delivery systems for microparticles |
GB9112553D0 (en) * | 1991-06-11 | 1991-07-31 | Wellcome Found | Fusion proteins |
ZA934199B (en) * | 1992-06-18 | 1994-01-10 | Akzo Nv | Carrier system against gnrh |
ES2095001T5 (es) * | 1992-12-22 | 2001-03-16 | Univ Cincinnati | Una composicion terapeutica administrable oralmente y su metodo de obtencion. |
US5681571A (en) * | 1993-10-08 | 1997-10-28 | Duotol Ab | Immunological tolerance-inducing agent |
US5688506A (en) * | 1994-01-27 | 1997-11-18 | Aphton Corp. | Immunogens against gonadotropin releasing hormone |
US6030613A (en) * | 1995-01-17 | 2000-02-29 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
US6485726B1 (en) | 1995-01-17 | 2002-11-26 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of therapeutics |
ATE331438T1 (de) * | 1995-01-17 | 2006-07-15 | Brigham & Womens Hospital | Rezeptorspezifischer transepithelealer transport von immunogenen |
US6086875A (en) * | 1995-01-17 | 2000-07-11 | The Brigham And Women's Hospital, Inc. | Receptor specific transepithelial transport of immunogens |
EP0840796A2 (en) * | 1995-07-26 | 1998-05-13 | Maxim Pharmaceuticals | Mucosal delivery of polynucleotides |
DE19534579C2 (de) * | 1995-09-18 | 2000-06-08 | Max Planck Gesellschaft | Nucleinsäure-Moleküle codierend Proteine, die die Adhäsion von Neisseria-Zellen an humane Zellen vermitteln |
US6942861B2 (en) | 1996-04-19 | 2005-09-13 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Histidine-tagged intimin and methods of using intimin to stimulate an immune response and as an antigen carrier with targeting capability |
US6261561B1 (en) | 1996-04-19 | 2001-07-17 | Henry M. Jackson Foundation For The Advancement Of Military Medicine | Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens |
US6818222B1 (en) | 1997-03-21 | 2004-11-16 | Chiron Corporation | Detoxified mutants of bacterial ADP-ribosylating toxins as parenteral adjuvants |
KR20010043441A (ko) | 1998-05-08 | 2001-05-25 | 더 유니버시티 오브 브리스톨 | 백신용 면역조절제 |
US7087236B1 (en) | 1998-09-01 | 2006-08-08 | Merrion Research I Limited | Method for inducing a cell-mediated immune response and improved parenteral vaccine formulations thereof |
ES2233284T3 (es) | 1999-02-17 | 2005-06-16 | Pfizer Products Inc. | Proteinas de fusion que comprenden portadores que pueden inducir una bdoble respuesta inmune. |
FR2791895B1 (fr) * | 1999-03-23 | 2001-06-15 | Pasteur Merieux Serums Vacc | Utilisation de trehalose pour stabiliser un vaccin liquide |
ATE444081T1 (de) * | 1999-10-22 | 2009-10-15 | Us Gov Health & Human Serv | Proteine-abgabe durch polare epithelzellen schichte |
AU2471201A (en) * | 1999-10-26 | 2001-06-06 | Chiron Corporation | Plant lectins as mucosal adjuvants |
US6863896B1 (en) | 1999-10-26 | 2005-03-08 | Chiron Corporation | Plant lectins as mucosal adjuvants |
JP2001335510A (ja) * | 2000-05-23 | 2001-12-04 | Masanori Baba | エイズワクチン |
CN102366630B (zh) * | 2003-03-07 | 2015-04-01 | 惠氏控股公司 | 用于抗医院内感染的免疫的多糖-葡萄球菌表面粘附素载体蛋白缀合物 |
ATE443870T1 (de) * | 2004-07-20 | 2009-10-15 | Symphogen As | Verfahren zur charakterisierung einer polyklonalen zellinie |
EP1804832A4 (en) | 2004-10-04 | 2008-12-24 | Trinity Biosystems Inc | METHOD AND COMPOSITIONS FOR THE NADLESS DELIVERY OF MACROMOLECULES |
US8420102B2 (en) | 2006-03-07 | 2013-04-16 | Vaxinnate Corporation | Compositions that include hemagglutinin |
ES2370040T3 (es) | 2005-10-07 | 2011-12-12 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.R.L. | Vacuna de metaloproteinasa 11 de la matriz. |
CA2631952A1 (en) | 2005-12-05 | 2007-06-14 | Trinity Biosystems, Inc. | Methods and compositions for needleless delivery of antibodies |
CN104080475A (zh) | 2008-04-18 | 2014-10-01 | 法克斯因内特公司 | 鞭毛蛋白的缺失突变体以及使用方法 |
BRPI1011753B8 (pt) | 2009-06-22 | 2021-05-25 | Wyeth Llc | conjugados imunogênicos de polissacarídeo capsular de staphylococcus aureus de sorotipos 5 e 8, seu uso e composições que os compreendem |
CA2766629C (en) | 2009-06-22 | 2020-03-24 | Wyeth Llc | Immunogenic compositions of staphylococcus aureus antigens |
CN101921726B (zh) * | 2010-07-27 | 2012-08-22 | 浙江大学 | 一种口服免疫阻断鸡抑制素作用的转化子及其应用 |
CN102178699B (zh) * | 2011-04-20 | 2013-03-20 | 威海康博尔生物药业有限公司 | 一种用于增强人体免疫力、促进生长发育的制剂 |
US8932598B2 (en) | 2012-08-28 | 2015-01-13 | Vaxinnate Corporation | Fusion proteins and methods of use |
US10617650B2 (en) | 2015-10-16 | 2020-04-14 | Merck Sharp & Dohme Corp. | Process for preparing formulations for gastrointestinal-targeted therapies |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2547224A1 (de) * | 1974-11-01 | 1976-05-13 | Sandoz Ag | Organische verbindungen, ihre verwendung und herstellung |
FR2306684A1 (fr) * | 1975-04-11 | 1976-11-05 | Crinex Lab | Nouvelle composition a action immunostimulante |
GB1553664A (en) * | 1975-06-12 | 1979-09-26 | Unilever Ltd | Antigenic compositions |
ZA802992B (en) * | 1979-06-01 | 1981-10-28 | Univ California | Human pre-growth hormone |
JPS5639022A (en) * | 1979-09-05 | 1981-04-14 | Hayashibara Biochem Lab Inc | Preparation of vaccine |
IT1144705B (it) * | 1980-03-17 | 1986-10-29 | Harvard College | Produzione ottimale di polipeptidi con impiego di geni fusionati |
EP0049945A3 (en) * | 1980-09-15 | 1982-12-01 | Bactex Incorporated | Determining a hierarchy of piliated organisms and a vaccine prepared from such organisms |
GB2094314A (en) * | 1981-02-05 | 1982-09-15 | Wellcome Found | Recombinant DNA |
WO1982003088A1 (en) * | 1981-03-09 | 1982-09-16 | Corp Cetus | Vaccines |
US4593002A (en) * | 1982-01-11 | 1986-06-03 | Salk Institute Biotechnology/Industrial Associates, Inc. | Viruses with recombinant surface proteins |
CA1203164A (en) * | 1982-03-09 | 1986-04-15 | Thomas J. Mckearn | Antibody conjugates |
DE3369466D1 (en) * | 1982-05-12 | 1987-03-05 | Harvard College | Fused genes encoding hybrid proteins, cloning vectors containing them and the use thereof |
US4496538A (en) * | 1982-07-06 | 1985-01-29 | Connaught Laboratories, Inc. | Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine |
EP0116201B1 (en) * | 1983-01-12 | 1992-04-22 | Chiron Corporation | Secretory expression in eukaryotes |
DK219084D0 (da) * | 1984-05-02 | 1984-05-02 | Frederik Carl Peter Lindberg | Antigen |
WO1985004654A1 (en) * | 1984-04-06 | 1985-10-24 | Scripps Clinic And Research Foundation | A peptide vaccine or diagnostic, and a polypeptide useful therefor |
US4808700A (en) * | 1984-07-09 | 1989-02-28 | Praxis Biologics, Inc. | Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers |
EP0177343B1 (en) * | 1984-10-05 | 1992-07-22 | Genentech, Inc. | Dna, cell cultures and methods for the secretion of heterologous proteins and periplasmic protein recovery |
NZ213759A (en) * | 1984-10-19 | 1989-01-27 | Genentech Inc | Lhrh-ctp protein conjugates influencing prolactin fsh and lh release |
US4556555A (en) * | 1985-01-25 | 1985-12-03 | North Carolina State University | Process for the immunological neutering of animals |
-
1986
- 1986-05-13 IL IL78775A patent/IL78775A/xx not_active IP Right Cessation
- 1986-05-14 DE DE3650082T patent/DE3650082T3/de not_active Expired - Fee Related
- 1986-05-14 WO PCT/AU1986/000135 patent/WO1986006635A1/en active IP Right Grant
- 1986-05-14 ES ES554969A patent/ES8900006A1/es not_active Expired
- 1986-05-14 NZ NZ216162A patent/NZ216162A/en unknown
- 1986-05-14 EP EP86903134A patent/EP0222835B2/en not_active Expired - Lifetime
- 1986-05-15 CN CN198686103835A patent/CN86103835A/zh active Pending
- 1986-05-15 CA CA000509225A patent/CA1340555C/en not_active Expired - Fee Related
-
1987
- 1987-01-14 DK DK016487A patent/DK171846B1/da not_active IP Right Cessation
- 1987-01-14 FI FI870140A patent/FI870140A0/fi not_active Application Discontinuation
-
1995
- 1995-01-05 JP JP7015505A patent/JP2761849B2/ja not_active Expired - Lifetime
-
1996
- 1996-02-15 HK HK29896A patent/HK29896A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
EP0222835B1 (en) | 1994-09-28 |
HK29896A (en) | 1996-02-23 |
EP0222835B2 (en) | 2000-04-19 |
IL78775A (en) | 1992-06-21 |
JPH07213290A (ja) | 1995-08-15 |
DE3650082T3 (de) | 2000-12-21 |
DK16487A (da) | 1987-03-16 |
DE3650082D1 (de) | 1994-11-03 |
JP2761849B2 (ja) | 1998-06-04 |
CA1340555C (en) | 1999-05-25 |
FI870140A0 (fi) | 1987-01-14 |
DE3650082T2 (de) | 1995-05-04 |
CN86103835A (zh) | 1987-04-08 |
WO1986006635A1 (en) | 1986-11-20 |
ES8900006A1 (es) | 1988-10-16 |
DK16487D0 (da) | 1987-01-14 |
AU594059B2 (en) | 1990-03-01 |
IL78775A0 (en) | 1986-08-31 |
NZ216162A (en) | 1989-04-26 |
EP0222835A4 (en) | 1988-02-01 |
AU5861286A (en) | 1986-12-04 |
DK171846B1 (da) | 1997-06-30 |
EP0222835A1 (en) | 1987-05-27 |
ES554969A0 (es) | 1988-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI861724A0 (fi) | Flockulationsprocess. | |
FI870140A0 (fi) | Orala vacciner. | |
FI852704L (fi) | Eldriven pipett. | |
FI860877A (fi) | Silanordning. | |
FI860186A0 (fi) | Spirodioxolan, -ditiolan och -oxotiolan. | |
FI861456A0 (fi) | Strykanordning. | |
DE3678182D1 (de) | Perfluorpolycycloalkane. | |
FI853781A0 (fi) | Tryckregleringssystem och -anordning foer automatisk noninvasiv blodtrycksmaetares manschett. | |
FI860584A (fi) | Blodtrycksnedsaenkande dihydropyridinderivat. | |
FI861668A (fi) | Antipsykotisk benzisotiazol-5-oxidfoerening. | |
FI854404A0 (fi) | Glidlagerkonstruktion. | |
FI854932A (fi) | Balningspress. | |
FI861495A (fi) | Vaendcentrifug. | |
FI861921A (fi) | Larvicida kompositioner. | |
FI860703A0 (fi) | Genomloppsaonggenerator. | |
FI861180A0 (fi) | Oljekyld slagkolv foer en foerbraenningsmotor. | |
FI860439A0 (fi) | Serietransmissionsanordning. | |
FI853726L (fi) | Traodloest saekerhetsalarmsystem. | |
FI861540A (fi) | Stoed foer en drag- och slagdaempningsanordning. | |
FI854045A0 (fi) | Hydraulisk spikningsmaskin foer loesspikar. | |
FI853833L (fi) | Brygga. | |
FI851428A0 (fi) | Skyddskonstruktion foer en vakuumventil. | |
FI854701A0 (fi) | Faergkoderingsfoerfarande foer digitala videobildoeverfoeringsanordningar. | |
FI850132A0 (fi) | Fyrastraolinfraroedfuktighetsmaetare. | |
FI854326A0 (fi) | Isskrapa. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |
Owner name: BIOTECHNOLOGY AUSTRALIA PTY. LTD |